By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innate Pharma 

Grand Pré
119/121 Ancien Chemin De Cassis
Marseille      France
Phone: 33-0-4-96-19-05-50 Fax: 33-04-96-19-05-55


Company News
Innate Pharma (IPH.PA ) Presents New CD73 Checkpoint Inhibitor Program 4/19/2016 7:59:06 AM
Innate Pharma (IPH.PA ) In-Licenses Orega Biotech's First-In-Class Anti-Cd39 Checkpoint Inhibitor Program 1/11/2016 11:46:28 AM
Sanofi (SNY) Deepens Cancer Push by Deals with MA Startup Warp Drive Bio and Innate Pharma (IPH.PA ) Worth $1.2 Billion 1/11/2016 6:02:51 AM
IPC, The Comprehensive Cancer Center Of Marseille, And Innate Pharma (IPH.PA ) Collaborate On Translational Research For Novel Immune Checkpoint Inhibitors 7/30/2015 9:26:58 AM
Innate Pharma (IPH.PA ) Strikes Cancer Pact Worth $1.275 Billion With Pharma Giant AstraZeneca PLC (AZN) 4/24/2015 6:04:49 AM
Innate Pharma (IPH.PA ) : DSMB Recommends Continuation Of Effikir Trial With Two Arms 3/30/2015 6:54:50 AM
Innate Pharma (IPH.PA ) Collaborates With NCIC Clinical Trials Group On The Phase I/II Trial Of IPH2201 In Ovarian Cancer 3/9/2015 7:30:38 AM
Innate Pharma (IPH.PA ) : Annual Results 2014: Stronger Cash Position And Expanded Clinical Portfolio 2/19/2015 8:34:09 AM
Innate Pharma (IPH.PA ): First Phase 2 Trial With IPH2201 Open In Head And Neck Cancer 12/19/2014 7:44:26 AM
Innate Pharma (IPH.PA ) Announces Its 2015 Financial Calendar As Well As Its Participation In Upcoming Investor Conferences 12/5/2014 10:29:46 AM